Epilepsy Research and Treatment / 2016 / Article / Tab 2

Research Article

Prevalence of Different Combinations of Antiepileptic Drugs and CNS Drugs in Elderly Home Care Service and Nursing Home Patients in Norway

Table 2

Antiepileptic drug use among patients () in home care services (HCS) and nursing homes. The association (odds ratio, OR) and 95% confidence interval (CI) for use of the drugs, adjusted for patients’ age, gender, and total number of drugs used in different settings (home care service used as reference).

Drug⁢Home care services ()⁢Nursing homes ()⁢All patients ()ORCI
%%%

Carbamazepine13421.05522.418921.40.880.61–1.26
Pregabalin9514.95020.414516.40.800.54–1.18
Lamotrigine10216.03213.113415.21.150.74–1.79
Gabapentin10416.32911.813315.11.721.09–2.70
Valproate6610.42711.09310.50.780.48–1.26
Clonazepam609.42711.0879.90.790.49–1.29
Phenobarbital487.5156.1637.11.260.68–2.31
Levetiracetam497.7124.9616.91.460.76–2.81
Phenytoin294.6104.1394.41.080.51–3.99
Oxcarbazepine111.7104.1212.40.360.15–0.86
Topiramate40.610.450.61.290.14–11.83
Zonisamide30.50030.3
Primidone10.20010.1

Total706268974

Not marketed in Norwegian. Some patients used more than one antiepileptic drug. OR, odds ratio; CI, confidence interval (95%).

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.